Indaco Capital

ReLive is a biotechnology company specializing in regenerative medicine and cell therapy. It develops products focused on orthopedic sports medicine, plastic surgery, and reconstructive surgery, aiming to treat joint cartilage injuries and defects.

Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on the development of small molecule drugs for cancer, viral infections, and autoimmune diseases.

Delova Biotech is a company dedicated to advancing pain treatment through the development of non-opioid analgesics. Leveraging extensive research and development experience, Delova Biotech focuses on enhancing existing drugs and creating innovative new analgesics in both China and the United States. The company employs advanced technology platforms, including long-acting injection technology, topical transdermal formulations, and nano-delivery systems, to improve drug efficacy. Additionally, Delova Biotech specializes in prodrug modification and enhancing solubility for insoluble drugs, aiming to deliver superior quality medications that enhance the quality of life for patients experiencing pain.

AcornMed specializes in tumor genetic testing and detection solutions, focusing on genomics to support precision medicine in oncology. The company offers advanced molecular diagnostics for both solid and blood tumors, facilitating comprehensive and personalized early detection test results for cancer patients. By integrating genomic insights into clinical practice, AcornMed aims to enhance the accuracy and effectiveness of cancer diagnosis and treatment.